What did @official_cynthia9154 actually say?
Not much, technically. The creator says "I was depressed before and now I found meaning," framing it as a before-and-after emotional transformation tied implicitly to peptide therapy given the hashtag context. The second line, "I didn't know you were depressed. Neither did I," suggests the depression was subclinical or unrecognized.
There is no specific peptide named. No dose mentioned. No mechanism explained. The video is more of a testimonial vibe than an actual claim, which matters a lot when we try to fact-check it. What we can evaluate is whether peptide therapy has any credible connection to mood improvement, and whether "finding meaning" after treatment is a documented phenomenon or just a good story.
To be fair to the creator, they never said "this peptide cured my depression." That restraint is worth noting, even if the platform and hashtags do most of the selling for them.
Does the science back this up?
There is emerging but very preliminary research connecting certain peptides to mood regulation. The key word is preliminary. Semax and selank, two peptides commonly discussed in the optimization space, have shown some anxiolytic and antidepressant-like effects in animal models and small Russian clinical trials, but none of this meets the evidentiary bar for Western clinical practice.
Semax has been studied for its effects on brain-derived neurotrophic factor (BDNF), a protein associated with mood regulation and neuroplasticity. Dolotov et al. (2006, Journal of Molecular Neuroscience) found that semax increased BDNF expression in rats. Selank has been evaluated in small Russian trials for generalized anxiety, with Zozulya et al. (2001, Bulletin of Experimental Biology and Medicine) reporting reduced anxiety scores, but sample sizes were tiny and regulatory bodies outside Russia have not reviewed this data.
GHK-Cu has been linked in vitro to nerve growth factor activity, and MK-677 raises IGF-1 levels, which some researchers associate with mood and cognitive function. None of this is a clean line from "take peptide, feel better."
What did they get wrong (or right)?
The creator did not get anything factually wrong because they did not make a factual claim. That is the actual problem. Testimonials like this one implicitly promise a result without stating a mechanism or acknowledging risk. That is a form of soft misinformation.
What they got right, inadvertently: unrecognized depression is a real and serious public health issue. Tadić et al. (2010, Psychopathology) documented that a significant portion of patients with depressive episodes do not identify as depressed until after treatment begins. The line "neither did I" is actually a clinically resonant observation, even if it landed inside a peptide TikTok.
What they got wrong by omission: peptide therapy for mood disorders is not an approved treatment. The FDA has not cleared any of the commonly discussed peptides for depression. Using unregulated peptide products without medical supervision carries real risks including injection site infections, hormonal disruption with compounds like MK-677, and unknown long-term effects. None of that context appears here.
What should you actually know?
If you watched this video and thought "maybe peptides fixed her depression and could fix mine," you need more information before acting on that. Depression is a heterogeneous condition with multiple subtypes and causes. Subclinical or unrecognized depression, like what the creator describes, can sometimes improve with lifestyle changes, exercise, or therapy, making it very difficult to attribute improvement to any single intervention.
The peptides most discussed in mood contexts, semax, selank, and to some extent BPC-157 via gut-brain axis hypotheses, are research chemicals in the United States. They are not FDA-approved. They are not standardized in terms of purity or dosing. Peptide therapy from a regulated telehealth provider looks very different from buying vials online and self-injecting based on TikTok content.
If you are experiencing depression, recognized or not, the appropriate first step is a licensed clinician, not a peptide stack. Some peptide therapies may eventually prove useful as adjuncts to mental health treatment, but that research is years away from clinical consensus.